Trial Profile
Sitagliptin Add-on to Sulfonylurea Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2012
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Alpha-glucosidase inhibitors; Gliclazide; Metformin; Thiazolidinediones
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 Sep 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 27 Apr 2011 New trial record